Evidence map›Paper›PMID 34316580›Full record

ArticleInfection prevention in practice2021

Validation and implementation of the Panbio COVID-19 Ag rapid test for the diagnosis of SARS-CoV-2 infection in symptomatic hospital healthcare workers.

E Kolwijck, M Brouwers-Boers, J Broertjes, K van Heeswijk, N Runderkamp, A Meijer, M H A Hermans, A C A P Leenders

Open access · goldAbstract read
In one paragraph

Article in Infection prevention in practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 5 pooled it
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 5 syntheses or guidelines pooled it, 15 citations in OpenAlex.

  1. The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Antigen Testing (January 2023).Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Guideline
  2. Pooled it
  3. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.The Cochrane database of systematic reviews · 2022
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

E KolwijckDepartment of Medical Microbiology, Jeroen Bosch Hospital, 's Hertogenbosch, the Netherlands.
M Brouwers-BoersDepartment of Medical Microbiology, Jeroen Bosch Hospital, 's Hertogenbosch, the Netherlands.
J BroertjesDepartment of Medical Microbiology, Jeroen Bosch Hospital, 's Hertogenbosch, the Netherlands.
K van HeeswijkDepartment of Medical Microbiology, Jeroen Bosch Hospital, 's Hertogenbosch, the Netherlands.
N RunderkampDepartment of Medical Microbiology, Jeroen Bosch Hospital, 's Hertogenbosch, the Netherlands.
A MeijerDepartment of Occupational Health, Jeroen Bosch Hospital, 's Hertogenbosch, the Netherlands.
M H A HermansDepartment of Medical Microbiology, Jeroen Bosch Hospital, 's Hertogenbosch, the Netherlands.
A C A P LeendersDepartment of Medical Microbiology, Jeroen Bosch Hospital, 's Hertogenbosch, the Netherlands.
Jeroen Bosch Ziekenhuis · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRT-PCR is the current recommended laboratory method to diagnose SARS-CoV-2 in healthcare workers (HCW). As RT-PCR is not widely available and is time-consuming, it limits decision making on removal from and return to work of possibly contagious HCW.

aimIn this study we evaluated the Panbio™ COVID-19 Ag rapid test (PanbioCAgRT) in 825 hospital HCW. METHODS AND FINDING: This study consisted of two phases. In the validation phase, we tested hospital HCW with mild symptoms (three days or less) in parallel using the PanbioCAgRT and the RT-qPCR test. The PanbioCAgRT demonstrated 86.7% sensitivity, 100% specificity, 100% PPV and 98.5% NPV with regard to RT-qPCR. For HCW with PanbioCAgRT-/RT-qPCR+, the median Ct value was 30.9, whereas for the HCW with PanbioCAgRT+/RT-qPCR+ the median Ct value was 19.3 (

conclusionThe PanbioCAgRTt validated in this study showed a high sensitivity and specificity in samples obtained from HCW with high viral loads. The antigen-based testing strategy proposed in this study seems to be effective, safe and easy to implement in a wide range of occupational healthcare settings.

Indexed as

COVID-19PanbioPoint-of-care testingRapid antigen detection testRT-PCRSARS-CoV-2

Identifiers

PMID34316580
PMCPMC8050397
OpenAlexW3154968678

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.